Stock Price
32.40
Daily Change
-2.35%
Yearly
-19.24%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 18.79 -1.15 -5.77% -65.36%
Agios Pharmaceuticals 34.22 -0.61 -1.75% -23.45%
Alnylam Pharmaceuticals 171.36 -11.49 -6.28% 32.26%
Amgen 202.44 1.27 0.63% -11.68%
Amarin 3.57 0 0% -28.74%
Aptinyx Inc 2.15 -0.13 -5.70% -42.97%
Arena Pharmaceuticals 49.55 -3.62 -6.81% -26.10%
Baxter International 78.05 1.82 2.39% 0.06%
Cara Therapeutics 12.31 -0.58 -4.50% -18.37%
Cytokinetics 35.50 -2.65 -6.95% 107.36%
DBV Technologies 2.72 -0.09 -3.20% 1.12%
Esperion Therapeutics 5.25 -3.72 -41.47% -82.60%
Five Prime Therapeutics 38.00 0 0% 1,339.39%
Halozyme Therapeutics 32.40 -0.78 -2.35% -19.24%
Intercept Pharmaceuticals 15.63 -1.41 -8.27% -55.85%
Immunogen 6.62 -0.54 -7.54% 9.97%
Ionis Pharmaceuticals 26.39 0.24 0.92% -48.48%
Intra Cellular Therapies 36.31 -2.31 -5.98% 44.26%
Jazz Pharmaceuticals 120.26 -2.44 -1.99% -20.20%
Eli Lilly 245.58 -2.30 -0.93% 65.43%
MannKind 4.17 -0.25 -5.66% 41.36%
Minerva Neurosciences 0.93 0.01 1.07% -66.20%
Nektar Therapeutics 10.83 -0.58 -5.08% -37.76%
Pfizer 54.27 1.23 2.32% 34.53%
Peregrine Pharmaceuticals 28.91 -2.59 -8.22% 156.75%
Rigel Pharmaceuticals 2.45 -0.16 -6.13% -20.45%
United Therapeutics 185.99 -3.30 -1.74% 39.35%
Vanda Pharmaceuticals 16.22 -0.35 -2.11% 21.50%
Intrexon 3.67 -0.32 -8.02% -56.67%

Indexes Price Day Year
NASDAQ 15085 -295.85 -1.92% 21.03%
US2000 2159 -47.02 -2.13% 14.10%

Halozyme Therapeutics
Halozyme Therapeutics, Inc. is a biopharma technology platform company. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine its ENHANZE drug delivery technology with the collaborators' compounds. The Company's lead enzyme, rHuPH20, is used to facilitate the delivery of injected drugs and fluids. The Company's approved product and its collaborators’ approved products and product candidates are based on rHuPH20, a patented recombinant human hyaluronidase enzyme. The Company's lead product, Hylenex recombinant, is a formulation of rHuPH20 that facilitates subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs and, in subcutaneous urography, to improve resorption of radiopaque agents. Its pipeline products include Herceptin SC, HYQVIA, DARZALEX and others.